Search clinical trials for: AMO-02-MD-2-003

Total 125733 results

AMO Pharma Limited

Completed

Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy

Congenital Myotonic Dystrophy

United States, Canada, New Zealand, Australia, United Kingdom
Galectin Therapeutics Inc.

Completed

A Single-dose, Open-label, Pharmacokinetic Study of Belapectin (GR-MD-02) in Subjects With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic Impairment

Hepatic Impairment

United States
Galectin Therapeutics Inc.

Completed

Phase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis

Non-Alcoholic Steatohepatitis (NASH)

United States
Providence Health & Services
Providence Cancer Center, Earle A. Chiles Research Institute; Galectin Therapeutics...

Completed

Galectin Inhibitor (GR-MD-02) and Ipilimumab in Patients With Metastatic Melanoma

Metastatic Melanoma

United States
Galectin Therapeutics Inc.

Completed

An Open-Label, Phase 2a Study to Evaluate Safety and Efficacy of GR-MD-02 for Treatment of Psoriasis

Psoriasis

United States
Providence Health & Services
Providence Cancer Center, Earle A. Chiles Research Institute

Withdrawn

GR-MD-02 + Pembrolizumab Versus Pembrolizumab Monotherapy in Melanoma and Squamous Cell Head and Neck Cancer Patients

Metastatic Melanoma | Head and Neck Squamous Cell Carcinoma

United States
Galectin Therapeutics Inc.

Active, not recruiting

Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis (NAVIGATE)

Cirrhosis | NASH - Nonalcoholic Steatohepatitis | Prevention of Esophageal Varices

United States, France, Spain, Australia, Canada, Israel, Puerto Rico, Belgium, Argentina, Chile, Germany, Korea, Republic of, Mexico, Poland, United Kingdom
AMO Pharma Limited

Recruiting

Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy (REACH CDM X)

Congenital Myotonic Dystrophy

United States, Canada, Australia, New Zealand
Providence Health & Services
Galectin Therapeutics Inc.

Completed

GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Patients

Melanoma | Non-Small Cell Lung Cancer | Squamous Cell Carcinoma of the Head and Neck

United States
Shenzhen NewDEL Biotech, Co., Ltd
Shenzhen Innovation Center for Small Molecule Drug Discovery Co., Ltd.

Enrolling by invitation

A Study to Evaluate Safety, Tolerability and Pharmacokinetic of ND-003 Tablets in Healthy Adults

Healthy

China
Galectin Therapeutics Inc.

Completed

Clinical Trial to Evaluate Efficacy of GR-MD-02 for Treatment of Liver Fibrosis in Patients With NASH With Advanced Fibrosis (NASH-FX)

Nonalcoholic Steatohepatitis

United States
Longbio Pharma

Recruiting

Efficacy and Safety of LP-003 in Moderate-to-severe Seasonal Allergic Rhinitis Adult

Seasonal Allergic Rhinitis

China
Galectin Therapeutics Inc.
Dr. Naga Chalasani, MD, Indiana University; Dr. Stephen A. Harrison, MD, Brooke...

Completed

Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis (NASH-CX)

Hypertension, Portal

United States
Genocea Biosciences, Inc.

Completed

Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine

Genital Herpes Simplex Type 2

United States
Longbio Pharma

Active, not recruiting

A Study of Single and Multiple Doses of LP-003 in Healthy Adult Participants

Chronic Spontaneous Urticaria

China
Interactive Medical Developments
University of Iowa; National Institutes of Health (NIH); Department of Health...

Unknown

MD.2 Medication Dispenser Medication Adherence Study

Frail Elderly | Medication Errors

United States
Medical University of Graz

Completed

Optical Quality After Implantation of a Spherical or Aspherical Intraocular Lens in Hypermetropic Patients

Cataract | Spherical Aberrations | Intraocular Lenses | Depth of Focus

Austria
AMO Pharma Limited

Completed

Study of Tideglusib in Adolescent and Adult Patients With Myotonic Dystrophy

Myotonic Dystrophy 1

United Kingdom
Alexander Kolevzon

Completed

AMO-01 to Treat Adolescents and Adults With Phelan-McDermid Syndrome (PMS) and Co-morbid Epilepsy

Epilepsy | Phelan-McDermid Syndrome

United States
MRC/UVRI and LSHTM Uganda Research Unit

Recruiting

Safety and Immunogenicity of LNP-nCOV saRNA-02 Vaccine Against SARS-CoV-2, the Causative Agent of COVID-19 (COVAC-Uganda)

COVID-19

Uganda
University Hospital, Angers

Completed

VASO-AM :Impact of Oral Appliance Therapy on Endothelial Function in Obstructive Sleep Apnea (VASO-AM)

Obstructive Sleep Apnea Syndrome

France
Theralase® Technologies Inc.
University Health Network, Toronto; Pharma eMarket

Recruiting

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG

United States, Canada
IInstituto Gallego de Medicina Vascular

Unknown

Study to Asses the Effect of Dapagliflozin on Central Blood Pressure Reduction.

Diabetes Mellitus, Type 2

Spain
Shanghai Yao Yuan Biotechnology Ltd. (also known...

Active, not recruiting

Evaluating the Safety, Tolerability, and Pharmacokinetics of DF-003 in Healthy Subjects

Healthy | Safety and Tolerability

United States
University of North Carolina, Chapel Hill
Naturex SA

Completed

Botanical Supplement Muscle Function and Lean Body Mass

Healthy Volunteers

United States
Nanjing Leads Biolabs Co.,Ltd
Henan Cancer Hospital; Hunan Cancer Hospital; Shandong Cancer Hospital and Institute

Completed

Evaluation of LBL-003 Phase I Study in Patients With Advanced Malignancies

Advanced Malignant Tumor

China
Durrie Vision
Alcon Research

Completed

Contralateral Comparison of Three Excimer Laser Systems in Performing LASIK (WLCVLV-001)

Astigmatism | Myopia

United States
Naurex, Inc, an affiliate of Allergan plc

Completed

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)

Depressive Disorder, Major

United States
Azura Ophthalmics
Syneos Health; Cliantha Research

Completed

A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)

Dry Eye | Meibomian Gland Dysfunction

Canada, Australia, New Zealand
Stemcentrx

Terminated

Study of SC-003 Alone and in Combination With ABBV-181 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer

Ovarian Cancer

United States
Hyundai Pharmaceutical Co., LTD.

Completed

Change From Baseline to Chronic Kidney Disease Patient Before and After Administration Drug

Chronic Renal Failure
Ankara University
Hacettepe University; The Scientific and Technological Research Council of...

Completed

The Effects of Insulin Detemir and Gliclazide-MR Treatments on Endothelial Functions in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Turkey
Huahui Health

Recruiting

A Study to Assess Efficacy and Safety of HH-003 Injection in Subjects With Chronic Hepatitis Delta Virus Infection

Chronic Hepatitis Delta Virus Infection

China
University Hospital, Lille
Celgene Corporation

Completed

IFM2009-02-Pomalidomide and Dexamethasone Phase 2 Myeloma (IFM2009-02)

Multiple Myeloma

France
BrightPath Biotherapeutics

Completed

Phase 1 Study of GRN-1201 in HLA-A*02 Subjects With Resected Melanoma

Melanoma

United States
University of Pennsylvania

Terminated

Penn Microbiome Therapy for Recurrent Clostridium Difficile Infection

Recurrent Clostridium Difficile Infection

United States
University Hospital, Clermont-Ferrand

Completed

AMO CROC Study: Self-medication and Dental Pain of Pulpal and Peri-apical Origin. Qualitative Study (AMO-CROC)

Self Medication

France
Azura Ophthalmics
ORA, Inc.

Recruiting

A Phase 3 Study to Evaluate AZR-MD-001 in Patients With Abnormal Meibomian Gland Function and Dry Eye Disease (DED)

Dry Eye Disease

United States
Sherief Abd-Elsalam

Recruiting

Impact of P53 and SIRT1 in Type 2 Diabetes

DM

Egypt
Pharma Two B Ltd.

Completed

A Phase 3 Study With P2B001 in Subjects With Early Parkinson's

Parkinson Disease | Early Parkinson's Disease

United States, Canada, Germany, Spain
University of Milan
University of Florence; University of Teramo

Not yet recruiting

Role of Ultra-processed Foods in Modulating the Effect of Mediterranean Diet (PROMENADE)

Overweight

Italy
Azura Ophthalmics
Avania

Completed

Evaluation of AZR-MD-001 in Patients With Meibomian Gland Dysfunction (MGD)

Meibomian Gland Dysfunction

Australia, New Zealand
Jeil Pharmaceutical Co., Ltd.

Recruiting

To Evaluate the Efficacy and Safety of JT-003 add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin

Type 2 Diabetes Mellitus

Korea, Republic of
ARC Devices
Cork University Hospital

Completed

Comparison of a Novel Non-Invasive, Non-Touch Infrared Thermometer With Routine Thermometry in Routine Clinical Practice

Healthy | Febrile

Ireland
University Hospital, Ghent
MEDA Pharma GmbH & Co. KG; University of Wuerzburg

Withdrawn

Study to Analyse Difference in Bioavailability Between MP29-02 and Fluticasone Propionate (BIODYMF)

Bioavailability Study

Belgium
Wave Life Sciences Ltd.

Recruiting

Study of WVE-003 in Patients With Huntington's Disease

Huntington Disease

Canada, Spain, Australia, Denmark, Netherlands, Poland, United Kingdom, France, Germany, Italy
Prolacta Bioscience

Completed

Safety Study of Human Milk Oligosaccharides in Healthy Adults

Healthy

United States
JOSE MANUEL SANCHEZ SAEZ

Completed

Evaluation of the Static Stability of Footwear (EEECS)

Postural; Strain

Spain
LUTRONIC Corporation

Completed

Lutronic LaseMD for Treatment of Benign Pigmented Lesions

Benign Pigmented Lesions

United States
Neurotec Pharma
Advancell - Advanced In Vitro Cell Technologies, S.A.

Completed

A Phase IIa Study of NT-KO-003 for Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis

Spain, Germany

Search clinical trials for: AMO-02-MD-2-003

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations